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Review
Trichloroethylene (TCE) is an industrial 
solvent that has been used extensively in 
industrial operations involving metal clean-
ing and degreasing. Its metabolism through 
a cytochrome P450 (CYP) pathway involv-
ing the enzyme CYP2E1 results in numer-
ous metabolites, including chloral, chloral 
hydrate, dichloro  acetic acid, trichloracetic 
acid, trichloro  ethanol, and trichloroethanol 
glucuronide (Lash et al. 2000). Many studies 
of immune-related effects of TCE have been 
conducted in the past decade, with much of 
this work focusing on auto  immune disease. 
We reviewed this recent research to determine 
the strength and consistency of data from 
experimental and epidemiologic studies, and 
the concordance between human and animal 
data, pertaining to these effects.
Materials and Methods
We searched PubMed (National Center for 
Biotechnology Information 2008) for stud-
ies related to TCE and immune effects, 
using forms of “immune,” “auto  immune,” 
“immuno  suppression,” “cytokines,” “lupus,” 
“scleroderma,” “rheumatoid arthritis,” “vas-
culitis,” and “liver” as search terms. We also 
reviewed references within relevant reports, 
including the National Academy of Sciences 
2006 report on TCE (National Research 
Council 2006). We did not include studies of 
in utero or developmental exposures (Blossom 
and Doss 2007; Blossom et al. 2007; Peden-
Adams et al. 2006, 2008) in this review. 
We abstracted data pertaining to 
immuno  suppression, hypersensitivity, and 
autoimmune-related effects, including clini-
cally expressed or clinically diagnosed disease, 
cytokine expression or levels, T-cell activa-
tion, and serology [antinuclear antibodies 
(ANA) and specific autoantibodies]. We pre-
sent, in tabular form, end points that all, or 
almost all, of the identified reports examined 
and include information on both “positive” 
and “negative” effects found in the studies.
We identified three case–control studies 
of scleroderma (systemic sclerosis) risk that 
included a specific assessment of occupational 
exposure to TCE in addition to more gen-
eral assessments of “solvent” or “organic sol-
vent” exposure (Diot et al. 2002; Garabrant 
et al. 2003; Nietert et al. 1998). We created 
graphical displays of the estimated meas-
ures of association from these studies using 
Comprehensive Meta Analysis, version 
2.2.046 (Biostat, Inc., Englewood, NJ). We 
conducted a meta-analysis of these studies 
using a random-effects model to include the 
possibility of non  random error between stud-
ies (DerSimonian and Laird 1986). Studies 
were too sparse to do sensitivity analyses or 
explore sources of heterogeneity or potential 
publication bias.
Results
Immunosuppression Studies 
Several animal studies have examined 
immuno  suppression and host resistance in 
relation to TCE exposures by various routes 
and concentrations of exposure. CD1 mice 
exhibited an increase in susceptibility to infec-
tious agents (e.g., Streptococcus zooepidimicus, 
Klebsiella pneumoniae) with short-term (3-hr) 
inhalation TCE exposures ranging from 
2.6 to 48 ppm (Aranyi et al. 1986). Another 
study in female CD1 mice provided evidence 
of decreased humoral immunity with oral 
exposure (via drinking water) to TCE at con-
centrations of 0.1, 1, 2.5, or 5 mg/mL for 
3–6 months (Sanders et al. 1982). Kauffmann 
et al. (1982) found similar results in a study of 
male and female CD1 mice exposed to a TCE 
metabolite, chloral hydrate, at concentrations 
of 0.07 and 0.7 mg/mL. After 3 days of sin-
gle intra  peritoneal (ip) injections of TCE in 
Sprague-Dawley rats at 0.05, 0.5, or 5 mmol/
kg/day and B6C3F1 mice at 10 mmol/kg/
day, natural killer cell activity in the liver, but 
not the spleen, was depressed in rats given 
the highest dose (22% lower than control 
levels, p < 0.05); in mice, a smaller decrease 
was reported (14% lower than control levels), 
which was not statistically significant (Wright 
et al. 1991). 
Data pertaining to measures of immuno-
suppression (e.g., infectious disease risk) in 
humans are very limited. In 1979, testing of 
wells in Woburn, Massachusetts, revealed that 
the water in two of the wells was contaminated 
with a number of solvents, including TCE 
(267 ppb) (Lagakos et al. 1986). In 1982, 
Lagakos et al. (1986) used a telephone sur-
vey of Woburn residents (representing ~ 57% 
of the town residences with listed telephone 
numbers) to collect information on residential 
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history and history of 14 types of medically 
diagnosed conditions for 4,978 children born 
since 1960 who lived in Woburn before they 
reached 19 years of age. Using exposure infor-
mation based on estimates of the contribu-
tion of water from the contaminated wells in 
various zones within the town, Lagakos et al. 
(1986) estimated a cumulative exposure based 
on each child’s length of residence in Woburn. 
They found that a higher cumulative exposure 
meas  ure was associated with a history of kid-
ney and urinary tract dis  orders (primarily kid-
ney or urinary tract infections) and with lung 
and respiratory dis  orders (asthma, chronic 
bronchitis, or pneumonia).
Studies of Generalized Hypersensitivity 
Skin Diseases with Other Systemic Effects
Occupational exposure to TCE has been asso-
ciated with a severe, generalized skin dis  order 
that is distinct from contact dermatitis in its 
clinical presentation (which often involves 
mucosal lesions) and in the accompanying 
systemic effects, which can include lymph-
ade  nopa  thy, hepatitis, and other organ involve-
ment. In two studies investigating delayed 
hypersensitivity using the guinea pig maxi-
mization test, sensitization rates of 66–71% 
and skin edema and erythema were observed 
(Tang et al. 2002, 2008). Elevations in liver 
enzymes and presence of liver lesions were also 
reported by Tang et al. (2008). In the guinea 
pig maximization test they found histopatho-
logic evidence of fatty degenera  tion in the liver, 
hepatic sinusoid dilation, and inflammatory 
cell infiltration with an acute intradermal dose 
of 4,500 mg/kg, and diffuse ballooning with-
out lymphocytic infiltration or necrotic hepato-
cytes with a total dosage of ≤ 340 mg/kg. 
Kamijima et al. (2007) reviewed case 
reports describing 260 patients, mostly from 
Asia, with TCE-related generalized skin dis-
orders. Their review is based on 26 articles 
published between 1966 and 2005 describing 
cases seen in China, Korea, Japan, Philippines, 
Singapore, Thailand, Spain, and the United 
States. One study in Guandong province, in 
southeastern China, included > 100 cases in 
a single year (Huang et al. 2002). Kamijima 
et al. (2007) categorized case descriptions 
as indicative of hypersensitivity syndrome 
(n = 124) or a variation of erythema multi-
forme, Stevens-Johnson syndrome, and toxic 
epiderma necrolysis (n = 115), with 21 other 
cases unclassified in either category. Hepatitis 
was common (> 50%), and the fatality rate 
(~ 10%) was similar in the two groups. Based 
on the reports reviewed by Kamijima et al. 
(2007), generalized skin disease within a work-
site occurred in 0.25–13% of workers in the 
same location performing the same type of 
work. The measured concentration of TCE 
ranged from < 50 mg/m3 to > 4,000 mg/m3, 
and exposure scenarios included inhalation 
only and inhalation with dermal exposures. 
Disease manifestation generally occurred 
within 2–5 weeks of initial exposure, with 
some intervals of up to 3 months. Most of 
the reports were published after 1995, and 
the geographic distribution of cases reflects 
the newly industrializing areas within Asia. 
An analysis of breathing zone concentrations 
of volatile organochlorines and metal con-
taminants of the solvents used in factories of 
25 workers hospitalized for hyper  sensitivity 
skin disease and at similar factories with no 
affected workers in the past 3 years indicated 
no commonality of additives or impurities 
detected among the affected factories that 
could explain the occurrence of the hyper-
sensitivity disorder (Kamijima et al. 2008).
Autoimmune Disease Studies
Autoimmune mouse models. Acceleration of 
auto  immune response. Several mouse strains 
spontaneously develop conditions resembling 
systemic lupus erythematosus seen in humans. 
These strains have been extensively used in 
mechanistic research pertaining to disease 
pathogenesis. The MRL-lpr and NZB × NZW 
mouse strains exhibit extremely high disease 
penetrance and early death. The MRL+/+ 
strain is less severely affected, with disease 
develop  ment after 12 months (compared with 
6–8 months in MRL-lpr and female NZB × 
NZW mice) and a relatively low prevalence 
of renal involvement. The MRL+/+ mouse has 
been used most often in experimental studies 
of TCE exposure (Table 1).
Several studies in MRL+/+ mice reported 
autoimmune-related effects from exposure 
to TCE via drinking water (Blossom et al. 
2004, 2007; Cai et al. 2008; Gilbert et al. 
1999; Griffin et al. 2000a, 2000b, 2000c; 
Wang et al. 2007b) or ip injection (Cai et al. 
2006; Khan et al. 1995) (Table 1). The ini-
tial drinking water study used relatively high 
TCE concentrations of 2.5 and 5 mg/mL, 
with serologic measurements of ANA and IgG 
levels and assays of activation of CD4+ T cells 
from spleno  cytes (Gilbert et al. 1999; Griffin 
et al. 2000a). Another study examined lower 
exposure levels (0.1, 0.5, and 2.5 mg/mL) and 
extended the observation to 32 weeks (Griffin 
et al. 2000b). These studies demonstrated an 
acceleration of the auto  immune response. 
T-cell activation peaked at 4–8 weeks in the 
higher-dose experi  ment and at 32 weeks in 
the lower-dose experiment. The higher dose 
study showed evidence of a reversal in effects 
at 22 weeks, with lower levels of CD4+ 
T-cell expression and interferon-γ (IFN-γ) in 
exposed mice compared with controls. The 
effects observed by Griffin et al. (2000a) with 
respect to formation of TCE–protein adducts 
and CD4+ T-cell activation were blocked in 
a parallel study of 2.5 mg/mL TCE via drink-
ing water in which the CYP2E1 metabolic 
pathway was inhibited by the addition of dial-
lyl sulfide (Griffin et al. 2000c). In another 
longer-exposure duration study using one 
dose group (0.5 mg/mL TCE in drinking 
water), Cai et al. (2008) found no evidence 
of systemic inflammation as determined by 
serum cytokines meas  ured after 36–48 weeks 
of exposure: levels of two proinflammatory 
cytokines, interleukin-6 (IL-6) and tumor 
necrosis factor-α (TNF-α), were decreased, 
but there was no difference in IL-1α. 
Several studies demonstrated the involve-
ment of one or more potential metabolites 
of TCE in the autoimmune response seen 
in MRL+/+ mice. These include studies of 
dichloro  acetyl chloride (Khan et al. 1995, 
2001), trichloroacetaldehyde hydrate (Blossom 
et al. 2004, 2007), and trichloroacetic acid 
(Blossom et al. 2004) (Table 1). Effects were 
similar to those found with TCE in terms of 
accelerated auto  antibody expression, T-cell 
activation, and secretion of inflammatory 
cytokines, but some differences in clinical 
expression were found in the long-term stud-
ies. B-cell activation has not been observed in 
studies using TCE (Griffin et al. 2000a) or its 
metabolites (Blossom et al. 2004).
Chronic effects. The three chronic oral 
exposure studies in the MRL+/+ mouse, with 
exposure periods of 32–48 weeks, reported 
the presence of distinct clinical effects in 
exposed mice (Table 1). One of these effects 
was characterized as an auto  immune hepatitis 
(Cai et al. 2008; Griffin et al. 2000b). Griffin 
et al. (2000b) found an inflammatory hepatic 
infiltrate in the portal tracts and lobular focal 
areas in the 0.5- and 2.5-mg/mL groups, with 
a dose-related effect on severity scores seen at 
32 weeks. Alanine amino  trans  ferase was also 
increased in the 0.5 mg/mL TCE dose group 
(means, 38.2 and 20.0 IU/L for 0.5 mg/mL 
and control groups, respectively). Cai et al. 
(2008) found similar liver lymphocytic infil-
trates at 36 weeks and 48 weeks in a study 
using 0.5 mg/mL TCE exposure in drinking 
water, and infiltrates in the pancreas, lungs, 
and kidneys at 48 weeks. In a 40-week study 
using trichloroacetaldehyde hydrate, Blossom 
et al. (2007) found clinical effects, including 
diffuse alopecia and skin inflammation and 
ulceration, with increasing incidence across 
the dose groups; the difference between the 
0.9 mg/mL group and the controls was statisti-
cally significant. Histologic examination of the 
skin lesions showed mono  nuclear cell infiltra-
tion, mast cell hyperplasia, and dermal fibrosis.
A chronic (26-week) drinking water expo-
sure study in NZB × NZW mice reported an 
increased level of proteinuria and prevalence 
of renal pathology, but no evidence of liver 
disease, with a TCE exposure of 10,000 ppb 
in drinking water (Gilkeson et al. 2004) 
(Table 1). Production of anti–double-stranded 
DNA (anti-dsDNA) and other anti  bodies Cooper et al.
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was increased at 1,400 ppb TCE (but not 
14,000 ppb) at 19 weeks; the differences less-
ened from 23 to 30 weeks and then increased 
between 32 and 34 weeks.
In a study in the male MRL-lpr/lpr mouse, 
Kaneko et al. (2000) exposed the mice via 
inhalation for 8 weeks to 0, 500, 1,000, or 
2,000 ppm TCE (4 hr/day, 6 days/week). IgG 
and IgM levels were reduced, but IgA levels 
and levels of T-helper and T-suppressor cells 
did not differ across exposures over the course 
of the study. The authors also found histologic 
changes in the liver and spleen, but not in the 
thymus, in the highest dose group (Table 1).
In vitro and mechanistic studies. Initial 
studies of TCE exposure in MRL+/+ mice 
noted the activation of a specific immune 
serum anti  body response directed against 
dichloro  acetylated proteins (Gilbert et al. 
1999; Griffin et al. 2000a; Khan et al. 1995). 
Immunohistochemical staining also revealed 
TCE-modified protein adducts in the liver 
and lung (Gilbert et al. 1999; Griffin et al. 
2000a). Cai et al. (2007) extended these 
observations using an experiment involving 
immunization of various albumin adducts 
(trichloroethene oxide, dichloroacyl, formyl, 
and trifluroacyl) injected subcutaneously for 0, 
2, or 4 weeks in groups of five female MRL+/+ 
mice. The authors used trifluroacyl albumin 
adduct as a positive control based on its role 
in halothane auto  immune liver disease. The 
immuno  genicity of the protein adducts was 
demonstrated by the increased albumin-spe-
cific IgG seen in all albumin-adduct–treated 
groups. Cross-reactivity between adducts was 
also evident. Although Cai et al. (2007) found 
no differences in serum liver enzymes (alanine 
amino  trans  ferase and aspartate amino  trans-
ferase), the formyl-albumin immunization 
resulted in a hepatic lymphocyte infiltration. 
These results suggest that the production of 
Table 1. Studies of TCE and metabolite effectsa in lupus mouse strains by strain, exposure route, and duration.
Strain, reference(s), exposure  Serology  Studies of cultured splenocytes  Clinical/histopathology results
Female MRL+/+ mice, drinking water 
Gilbert et al. 1999; Griffin et al. 2000a  Increased ANA at 4 and  Increased activated CD4+ T cells and  No evidence of liver or renal damage, based
  No. per group; 0, 2.5, 5 mg/mL TCE     8 weeks; no difference     IFN-γ secretion across doses at 4 weeks,    on serum alanine aminotransferase, sorbitol
  (average 0, 455, 734 mg/kg-day) for     between groups at 22 weeks    with effects reversed at 22 weeks;    dehydrogenase, and blood urea nitrogen
  4, 8, or 22 weeks       decreased IL-4 secretion (4 and 22 weeks)
Griffin et al. 2000c   Increased ANA in all treated  Increased activated CD4+ T cells (32 weeks)  Extensive hepatic mononuclear cellular
  8 per group; 0, 0.1, 0.5, or 2.5 mg/mL    groups at 4 weeks but not at    and IFN-γ secretion (4 and 32 weeks); no    infiltrate in 0.5 and 2.5 mg/mL groups;
  TCE (0, 21, 100, or 400 mg/kg-day) for    32 weeks    effect on IL-4 secretion    hepatocyte reactive changes in all treated 
  4 or 32 weeks        groups at 32 weeks
Blossom et al. 2004   Increased ANA and anti-histone  Increased activated CD4+ T cells at 0.1 and  No evidence of liver or kidney damage,
  6–8 per group; 0, 0.1, 0.9 mg/mL    antibodies at 0.9 mg/mL    0.9 g/mL doses of both metabolites;     based on serum alanine aminotransferase
  trichloroacetaldehyde hydrate (0, 24,    trichloroacetaldehyde hydrateb    increased IFN-γ secretion at     and liver and kidney histology
  220 mg/kg) or trichloroacetic acid      0.9 mg/mL; no effect on IL-4 secretion
  (0, 27, 205 mg/kg-day) for 4 weeks
Blossom et al. 2007   Slightly suppressed anti-ssDNA,  Increased activated CD4+ T-cells and   Diffuse alopecia, skin inflammation and
  8 per group, 0, 0.1, 0.3, 0.9 mg/mL    anti-dsDNA, and anti-histone    increased IFN-γ secretion; no effect on IL-4    ulceration, mononuclear cell infiltration, 
  trichloroacetaldehyde hydrate    antibody expression; differences     secretion    mast cell hyperplasia, and dermal fibrosis;
  (0, 13, 46, 143 mg/kg-day) for    not statistically significant      statistically significant increase at 0.9 mg/
  40 weeks        mL dose group but also increased at lower 
        doses; no liver or kidney histopathology 
        effects seen
Cai et al. 2008   Increased ANA after 24 weeks  Increased IFN-γ secretion after 36 weeks  Hepatic necrosis; hepatocyte proliferation;
  5 per group, 0 or 0.5 mg/mL TCE    but not statistically significant    but not statistically significant    leukocyte infiltrate in the liver, lungs, and 
  (mean 60 µg/g-day) for 48 weeks        kidneys; no difference in serum 
        aminotransferase liver enzymes
Female MRL+/+ mice, ip injection 
Khan et al. 1995   In both groups, increased ANA  Not evaluated  Not evaluated
  4–5 per group, in corn oil, 0 (corn oil),     and anti-ssDNA antibodies; in
  10 mmol/kg TCE, 0.2 mmol/kg    dichloroacetyl chloride group,
  dichloroacetyl chloride, every 4th day     anticardiolipin antibodies; no
  for 6 weeks    difference in anti-histone, -Sm, 
    or -DNA antibodies
Cai et al. 2006   In both treated groups,   In both treated groups, increased IL-1α,  In both treated groups, increased
  6 per group, in corn oil, 0 (corn oil),     increased ANA    IL-1β, IL-3, IL-6, IFN-γ, granulocyte    lymphocytes in spleen and thickening of
  0.2 mmol/kg dichloroacetyl chloride,       colony–stimulating factor, and    alveolar septa with lymphocytic interstitial
  0.2 mmol/kg dichloroacetic       keratinocyte-derived chemokine secretion     infiltration
  anhydride, twice per week for 6 weeks      and decreased IL-5; in dichloroacetyl 
      chloride group, increased IL-17 and IFN-αc 
Female NZB × NZW mice, drinking water
Gilkeson et al. 2004   Increased anti-dsDNA antibodies  Not evaluated  At 10,000 ppb, proteinuria increased
  6 per group, 0, 1,400, or 14,000 ppb,d    at some periods at ≥ 1,000 ppb      beginning at 20 weeks; renal pathology
  26 weeks exposure; observed up        scores increased; no signs of liver disease
  to 36 weeks
Male MRL –lpr/lpr, inhalation
Kaneko et al. 2000   Not evaluated  Not evaluated  At ≥ 500 ppm, dose-related liver
  5 per group, 0, 500, 1,000,         inflammation, splenomegaly, and
  2,000 ppm TCE, 4 hr/day,         hyperplasia of lymphatic follicles; 
  6 days/week for 8 weeks        at 1,000 ppm, immunoblastic cell formation 
        in lymphatic follicles; no changes in thymus
ssDNA, single-strand DNA. 
aSelected end points based on those reported across most studies. bNo difference reported in anti-dsDNA, anti-ss-DNA, anti-ribonucleosome, anti-SSA, anti-SSB, anti-Sm, anti-Jo-1, 
or anti-Scl-70 antibodies. cNo difference in secretion of other cytokines measured: IL-2, IL-4, IL-10, IL-12, TNF-α, granulocyte monocyte colony–stimulating factor, macrophage inflam-
matory protein-1α, and RANTES (CCL-5). dDose not given in mg/kg-day. Dose levels cited by Gilkeson et al. (2004) were incorrectly reported as 1,000 and 10,000 ppb; corrected doses 
(Peden-Adams MM, personal communication) are reported here. Autoimmune effects of TCE in mice and humans
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formyl-haptenized proteins from TCE may be 
a key factor in the development of the effects 
seen in the MRL+/+ mouse studies.
A series of experiments examined the 
role for oxidative stress, and specifically 
of lipid-peroxidation-derived aldehydes, in 
TCE-induced auto  immune disease. The 
hypothesized mechanism involves the bind-
ing of these reactive aldehydes to proteins 
to form neo  antigen targets for autoantibody 
formation. Wang et al. (2007a) detected 
malondialdehyde and 4-hydroxynonenal pro-
tein adducts (reflecting lipid peroxidation) 
in the livers of female MRL+/+ mice treated 
for 6 and 12 weeks with 10 mmol/kg TCE 
(every fourth day, by ip injection). The same 
group found anti  malondialdehyde anti  bodies 
and anti  hydroxynonenal antibodies with 4- 
to 12-week ip exposure to TCE (Khan et al. 
2001; Wang et al. 2007a, 2007b, 2008) and 
48-week oral exposure to TCE (Wang et al. 
2007b) or dichloro  acetyl chloride (Khan et al. 
2001). These antibodies were correlated with 
ANA (Wang et al. 2007a, 2007b). Wang et al. 
(2008) found proliferation and activation of 
splenic CD4+ T cells after stimulation with 
malondialdehyde-adducted or 4-hydroxy-
nonenal–adducted mouse serum albumin. 
Other studies have examined potential 
mechanisms through which TCE-related com-
pounds affect T-cell stimulation and apopto-
sis. In a short-term (4-week) exposure study, 
Blossom et al. (2004) found a dose-related 
inhibition of anti-CD3–mediated (activation-
induced) apoptosis of CD4+ T cells with oral 
exposures to 0, 0.1, and 0.9 mg/mL trichloro-
acetaldehyde hydrate. With a longer exposure 
period (40 weeks), however, they found no 
effect on anti-CD3–mediated apoptosis of 
CD4+ T cells and no difference in expression 
of Fas or Fas ligand (Blossom et al. 2007). This 
difference paralleled a difference in metallo-
proteinase-7 levels, which were elevated at 
4 weeks but not at 40 weeks (Blossom et al. 
2007; Blossom and Gilbert 2006).
Other rodent models. The Brown 
Norway rat has been used as a model 
of chemical-induced complex-mediated 
glomerulo  nephritis, for example, in studies of 
mercuric chloride (Sapin et al. 1977). The dis-
ease is complex-mediated, similar to that seen 
in humans with systemic lupus erythematosus. 
Polyclonal stimulation and increased IgE lev-
els are hallmarks of the disease in the Brown 
Norway rat. White et al. (2000) administered 
TCE by gavage to female Brown Norway rats 
for 6 weeks (100, 200, or 400 mg/kg, 6–8 ani-
mals per dose) and found no increase in IgE 
compared with the vehicle controls. 
In the study of NZB × NZW mice 
described above, Gilkeson et al. (2004) also 
included a parallel study of B6C3F1 mice, a 
model that typically does not develop auto-
immune sequelae. Increases in anti-dsDNA 
antibodies were statistically significant or of 
borderline significance (p = 0.07) at all times 
after 26 weeks exposure to 1,400 ppb or 
14,000 ppb TCE via drinking water. 
Epidemiologic Studies
Measures of immune function and mark-
ers. The available data from studies in 
humans also provide evidence of an associa-
tion between increased TCE exposure and 
cytokine meas  ures indicative of an inflam-
matory immune response (Table 2). Iavicoli 
et al. (2005) examined cytokine levels in 35 
male TCE-exposed workers (degreasers) from 
a printing area of a factory in Italy and com-
pared these workers with two control groups: 
other male factory workers not involved in 
degreasing activities (n = 30) and male office 
workers at the factory (n = 40). The mean 
TCE concentration among exposed workers 
was approximately 35 mg/m3. The authors 
observed no difference in serum cytokine con-
centrations (meas  ured using enzyme-linked 
immuno  sorbent assays) between the two con-
trol groups, but they found considerable dif-
ferences in the exposed group compared with 
the non  exposed workers (for all, p < 0.01): 
exposed workers had lower IL-4 levels and 
higher IL-2 and IFN-γ levels (Table 2). 
Two other studies measured the percent-
age of cytokine-secreting CD3+ (or CD3+ and 
CD8+) T cells in relation to measures of TCE 
exposure from indoor air samples. Lehmann 
et al. (2001) found no association in the pilot 
study conducted with 28 children 36 months 
of age, but a larger study of 85 infants (4 weeks 
of age) reported a decrease in the popula-
tion of IL-4–secreting cells and an increase 
in IFN-γ–secreting cells in relation to higher 
exposure to TCE (defined as > 75th percentile 
of the distribution) (Lehmann et al. 2002).
Byers et al. (1988) collected serum sam-
ples from 23 family members of leukemia 
patients in Woburn. They used these sam-
ples to assess the presence of auto  antibodies 
(ANA, anti-smooth muscle, anti  ovarian, 
anti  thyroglobulin, and anti  microsomal anti-
bodies) in the family member samples and 
compared the results with laboratory refer-
ence values. None of the serum samples from 
family member contained anti  thyroglobulin 
or anti  microsomal anti  bodies, but ANA were 
detected in samples from 10 (43%) family 
members (compared with < 5% expected 
based on the reference value). 
The aquifer of the Santa Cruz River in 
Tucson, Arizona, had been contaminated 
with solvents (primarily TCE) and heavy met-
als (e.g., chromium). Kilburn and Warshaw 
(1992, 1993) examined the prevalence 
of connective tissue disease symptoms and 
ANA, comparing 362 residents of Tucson to 
158 residents of another area of southwest 
Arizona. They selected the Tucson residents 
from the neighborhoods with documented 
water contamination (> 5 ppb TCE for at 
least 1 year between 1957 and 1981). The 
recruitment process was not described clearly, 
but in Tucson it seems to have specifically 
involved patients with lupus or other rheu-
matic diseases (Kilburn and Warshaw 1992, 
1993). In contrast, they recruited the com-
parison group through a Catholic parish. The 
prevalence of some self-reported symptoms 
(malar rash, arthritis/arthalgias, Raynaud syn-
drome, skin lesions, and seizure or convul-
sion) and of low-titer (1:80) ANA was higher 
in Tucson (Kilburn and Warshaw 1992). It 
is difficult to attribute these differences to the 
water supply, however, given the process that 
went into participant recruitment (with part 
of the Tucson group selected based on the 
presence of rheumatic diseases) and the lack 
of verification of the self-reported symptoms.
Systemic autoimmune diseases. Interest in 
the role of chlorinated compounds in auto-
immune diseases was spurred by the observa-
tion of a scleroderma-like disease in workers 
exposed to vinyl chloride (Gama and Meira 
Table 2. Studies of cytokines and TCE exposure in humans.
Reference, location, no., and age  Source of exposure data, outcome measures  Results
Iavicoli et al. 2005   Urine sample (for trichloroacetic acid concentration);  Nonexposed workers similar to office controls for all cytokine measures;
  Italy; 35 exposed workers,     workplace TCE measures (personal samples,     compared with nonexposed workers, TCE-exposed workers had
  30 nonexposed workers,    4 exposed and 4 nonexposed workers); questionnaire    decreased IL-4 (mean, 3.9 vs. 8.1 pg/mL), increased IL-2 (mean, 798 vs.
  and 40 office worker controls,     (smoking history, age, residence); serum cytokine levels    706 pg/mL), and increased IFN-γ (mean, 37.1 vs. 22.9 pg/mL)
  all male; mean age ~ 33 years
Lehmann et al. 2001   Indoor air sampling (child’s bedroom) of 28 volatile  TCE exposure not associated with percentages of IL-4 CD3+ or IFN-γ
  Germany; 28 children,     organic chemicals; cytokine-secreting CD3+ and CD8+     CD8+ T-cells
  36 months of age    T cell populations from blood sample
Lehmann et al. 2002   Indoor air sampling (child’s bedroom) of 28 volatile organic  Increasing TCE levels associated with decreased IL-4 (OR = 4.4; 95% CI,
  Germany; 85 newborns    chemicals (4 weeks after birth); cytokine-secreting CD3+    1.1–17.8) for < 25th percentile IL-4 and increased IFN-γ (OR = 3.6; 95% CI,
    T cell populations from CD3+ cord blood cells    0.9–14.9) for > 75th percentile IFN-γ; no association with TNF-α or IL-2 Cooper et al.
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1978), and several case reports focused on 
TCE (Flindt-Hansen and Isager 1987; Lockey 
et al. 1987; Saihan et al. 1978). Larger epide-
miologic studies (case–control or population-
registry–based designs) using broad measures 
of occupational exposure to solvents, organic 
solvents, or chlorinated solvents generally 
reported a 2- to 3-fold increased risk of sys-
temic sclerosis (sclero  derma) (Aryal et al. 
2001; Garabrant et al. 2003; Maitre et al. 
2004), rheumatoid arthritis (Lundberg et al. 
1994; Sverdrup et al. 2005), undifferentiated 
connective tissue disease (Lacey et al. 1999), 
and anti-neutrophil-cytoplasmic antibody 
(ANCA)–related vasculitis (Beaudreuil et al. 
2005; Lane et al. 2003), but similar associa-
tions have not been found in studies of lupus 
(Cooper et al. 2004; Finckh et al. 2006).
Two case–control studies of scleroderma 
(Bovenzi et al. 2004; Maitre et al. 2004) and 
two of rheumatoid arthritis (Olsson et al. 2000, 
2004) provided data concerning solvent expo-
sure that occurred among metal workers or in 
jobs that involved cleaning metal (i.e., types of 
jobs that were likely to use TCE as a solvent). 
Olsson et al. (2000, 2004) found a 2-fold 
increased risk among male workers in stud-
ies of rheumatoid arthritis from Sweden. The 
results from the smaller studies of scleroderma 
were more variable: Maitre et al. (2004) found 
Table 3. Epidemiologic studies of TCE exposure and risk of scleroderma and other autoimmune diseases.
Disease, reference, location,  Exposure definition/prevalence
period, sample size, age   Source of exposure data  Cohort  Cases (%)  Controls (%)  OR (95% CI)
Scleroderma (systemic sclerosis)
Nietert et al. 1998   Structured interview (specific jobs and materials;  Men
  South Carolina; prevalent cases,     jobs held ≥ 1 year); classified by expert review    Any exposurea  51   42   2.0 (0.8–4.9)
  1995–1997; 178 cases (141 women,     (job exposure matrix)     Maximum intensity  30   10   3.3 (1.0–10.3)
  37 men), 200 hospital-based controls;       Cumulative intensity  32   21   2.0 (0.7–5.3)
  mean age at onset, 45.2 years      Maximum probability  16   3   5.1 (NC)
    Women 
      Any exposurea  19   24   0.7 (0.4–1.3)
      Maximum intensity  6   7   0.9 (0.3–2.3)
      Cumulative intensity  10   9   1.2 (0.5–2.6)
      Maximum probability  4   5   0.7 (0.2–2.2)
Diot et al. 2002   Structured interview (specific jobs and materials;  Men and women
  France; prevalent cases     jobs held ≥ 6 months); classified by expert review    Any exposure  16   8   2.4 (1.0–5.2)
  hospitalized 1998–2000; 80 cases       High exposureb  9   1   7.6 (1.5–37.4)
  (69 women, 11 men), 160 hospital    Men
  controls; mean age at diagnosis,       Any exposure  64   27   4.7 (0.99–21.9)
  48 years    Women
      Any exposure  9   4   2.1 (0.65–6.8)
Garabrant et al. 2003  Structured interview (specific jobs and materials;  Women
  Michigan and Ohio; prevalent cases    jobs held ≥ 3 months); classified by self-report    Self-report, any exposure  1.3   0.7   2.0 (0.8–4.8)
  diagnosed 1980–1992; 660 cases    and expert review    Expert review, any exposure  0.7   0.4   1.9 (0.6–6.6)
  (all women), 2,227 population
  controls;c ages, ≥ 18 years
Undifferentiated connective tissue disease
Lacey et al. 1999   Structured interview (specific jobs and materials;  Women
  Michigan and Ohio; prevalent cases    jobs held ≥ 3 months); classified by self-report    Self-report, any exposure  0.5   0.7   0.88 (0.11–6.95)
  diagnosed 1980–1991 (Michigan),    and by expert review    Expert review, any exposure  0.5   0.4   1.67 (0.19–14.9)
  1980–1992 (Ohio); 205 cases (all
  women), 2,095 population controls;
  ages, ≥ 18 years
ANCA-related diseasesd
  Beaudreuil et al. 2005  Structured interview (specific jobs and materials;  Men and women
  France; incident cases diagnosed    jobs held ≥ 6 months); classified by expert review    Any exposure  18.3   17.5   1.1 (0.5 – 2.4)
  1999–2000; 60 cases (~ 50% women),      Data not presented separately
  120 hospital controls; mean age,      by sex
  61 years
NC, not calculated. 
aThe publication did not include “any” exposure, but this was generated by the original author (P. Nietert) as part of the present analysis. bProduct of probability × intensity × frequency 
× duration scores, summed across all jobs; scores of > 1 classified as “high.” cTotal number with TCE data: self-report 606 cases, 2,138 control; expert review 606 cases, 2,137 controls. 
dDiseases included Wegener glomerulonephritis (n = 20), microscopic polyangiitis (n = 8), pauci-immune glomerulonephritis (n = 10), uveitis (n = 6), Churg-Strauss syndrome (n = 4), 
stroke (n = 4), and other diseases (≤ 2 each).
Figure 1. Association between risk of scleroderma and occupational exposure to TCE in men (A) and women (B), based on data from three case–control studies 
(Diot et al. 2002; Garabrant et al. 2003; Nietert et al. 1998). The graphics show the estimated measures of association from these studies. The pooled estimates 
are based on a meta-analysis using a random-effects model to include the possibility of nonrandom error between studies. Each square and corresponding line 
represent the OR and 95% CI from the individual study, with the relative size of the squares reflecting the relative weights of the studies. The horizontal midpoint 
of each diamond represents the pooled OR estimate and the horizontal extremes indicate the 95% CI. 
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no exposed cases in a study with 93 cases and 
206 controls, and Bovenzi et al. (2004) found 
an odds ratio (OR) of 5.2 [95% confidence 
interval (CI), 0.7–37] in a study with 56 cases 
and 171 controls. 
Five other case–control studies provided 
data specifically about TCE exposure, based 
on industrial hygienist review of job history 
data (Table 3). Three of these studies are of 
scleroderma (Diot et al. 2002; Garabrant et al. 
2003; Nietert et al. 1998), one is of undif-
ferentiated connective tissue disease (Lacey 
et al. 1999), and one is of small vessel vas-
culitis involving ANCA (Beaudreuil et al. 
2005). These studies included some kind of 
expert review of job histories, but only two 
studies included a characterization of exposure 
level (e.g., a cumulative exposure metric) or 
a “high” exposure group (Diot et al. 2002; 
Nietert et al. 1998). Most of the studies pre-
sented data stratified by sex. The test for het-
erogeneity between results for males and those 
for females just missed statistical significance 
(p = 0.058). We decided that performing 
separate analyses for these groups was war-
ranted because the substantial gender-related 
differences in the background rate of sclero-
derma and in the prevalence of TCE exposure 
provide additional rationale for examining 
gender-related differences in meas  ures of asso-
ciation. In men, the studies generally reported 
ORs between 2.0 and 8.0, and in women, the 
ORs were between 1.0 and 2.0. The meta-
analysis of scleroderma studies with TCE 
exposure data (Diot et al. 2002; Garabrant 
et al. 2003; Nietert et al. 1998) resulted in 
a combined OR for “any” exposure of 2.5 
(95% CI, 1.1–5.4) for men and 1.2 (95% CI, 
0.58–2.6) for women (Figure 1). There was 
no clear support for heterogeneity within the 
male and female subgroupings (p = 0.35 for 
men and 0.16 for women).
Discussion
During the past decade there has been con-
siderable research, in experimental animals 
and in humans, pertaining to immune-related 
effects of TCE. Data concerning immuno-
suppression, particularly in humans, are still 
somewhat limited. In contrast, a fuller picture 
is shown by the studies of hypersensitivity, 
dermatitis, and hepatic injury, an emerging 
occupational concern in China and other 
industrializing areas.
The autoimmune-related studies, many 
of which were conducted in the past 5 years, 
represent a broad and robust literature, 
exhibiting many of the attributes that lend 
support for a causal relation between expo-
sure and disease, including strength, consis-
tency, dose–response patterns, and biological 
plausibility (Hill 1965; Legator and Morris 
2003). Autoimmune mouse strains with a 
relatively less severe lupus phenotype (i.e., 
delayed disease onset), such as seen in the 
MRL+/+ mouse, provide an experimental 
model to examine the acceleration of lupus 
pathology. Numerous studies using differ-
ent routes of exposure and dose ranges 
have demonstrated an accelerated autoim-
mune response in MRL+/+ mice. In the oral 
exposure studies, the duration of exposure 
period clearly influences the observed effects, 
with the acceleration (as measured by auto-
antibody production, T-cell activation, and 
inflammatory cytokine secretion or serum 
levels) generally seen with shorter exposures 
(Blossom et al. 2004; Griffin et al. 2000a, 
2000b), and clinical effects seen with longer 
exposure periods (Blossom et al. 2007; Cai 
et al. 2008; Gilkeson et al. 2004; Griffin et al. 
2000b). The different effects seen with short 
compared with long exposure durations in the 
MRL+/+ mouse experiments may reflect the 
varying disease course and varying response in 
specific target tissues during different phases 
of pathogenesis (Greidinger et al. 2007). It 
is interesting that the clinical effects seen in 
the MRL+/+ mouse chronic exposure studies 
(36–48 weeks) (Blossom et al. 2007; Cai et al. 
2008; Griffin et al. 2000b) differ somewhat 
from “normal” expression within these mice. 
That is, the effects seen included an inflam-
matory hepatic infiltrate, diffuse alopecia, and 
skin inflammation and ulceration.
Studies using autoimmune mouse strains 
also provide a means to examine potential 
mechanisms of action as well as the effects of 
various doses and durations of exposure. The 
formation of immunogenic TCE-induced 
adducts of liver proteins and lipid-peroxidation–
derived aldehydes and potential role of oxidative 
stress in promoting an aberrant autoimmune 
response to neoantigens in the liver and other 
tissues are some of the mechanistic hypotheses 
that have been raised by this research.
Data from experimental studies in non-
lupus-prone animals are limited. In a study 
in the Brown Norway rat, White et al. 
(2000) found no increase in IgE with gavage 
doses of up to 400 mg/kg-day for 6 weeks, 
but Gilkeson et al. (2004) found increases 
in anti-dsDNA antibodies in B6C3F1 mice 
after 26 weeks of exposure to 1,400 ppb or 
14,000 ppb via drinking water. 
Are the effects seen in the MRL+/+ mouse 
also seen in humans? Occupational stud-
ies have examined inflammatory cytokines 
and specific systemic auto  immune diseases, 
although our literature search did not find 
any studies of TCE exposure and either lupus 
or autoimmune liver disease. We found no 
cohort studies of the incidence of auto  immune 
diseases in workers exposed to TCE, but the 
available case–control studies of scleroderma 
and TCE support the relevance of this dis-
ease within the context of human exposures. 
Although the association is generally stronger 
in studies in men compared with those in 
women, it is not clear whether this difference 
reflects the relatively low background risk of 
scleroderma in men, differences in exposure 
prevalence or in the reliability of exposure 
assessment (Messing et al. 2003), or a gender-
related difference in susceptibility to the effects 
of TCE. Given the available studies in sclero-
derma and more limited data in other systemic 
autoimmune diseases, it is difficult to argue 
that the investigations into disease acceleration 
and variations in manifestations of effect seen 
in lupus-prone mice are irrelevant to humans. 
The variation in clinical expression of dis-
ease in response to TCE exposure remains an 
important research question to be addressed by 
both mechanistic and epidemiologic studies.
Systemic sclerosis (scleroderma) and 
auto  immune liver disease are relatively rare 
in humans, with incidence rates of about 
1/100,000 per year; incidence rates for sys-
temic lupus erythematosus are somewhat 
higher (5–10 per 100,000 per year) (Cooper 
and Stroehla 2003) but still low enough to 
present considerable challenges to perform-
ing adequately powered epidemiologic studies. 
An additional impediment to auto  immune 
disease research is the lack of disease registries, 
which adds to the difficulty in identifying inci-
dent cases of specific diseases. The insights gen-
erated by the recent experimental studies of 
TCE, however, provide a strong rationale for 
developing the type of multi  site collaborations 
needed to address the potential influence of 
TCE or other solvents operating through a 
similar pathway on the incidence of specific 
autoimmune diseases, and for evaluating the 
potential immune-related effects of low-level 
exposures from environmental contamination. 
Development and validation of exposure assess-
ment techniques incorporating occupational 
and environmental exposure pathways, use of 
quantitative exposure metrics, examination of 
multiple solvents and other agents, and stud-
ies of markers of immune function expressed 
before onset of disease would be instrumental 
in the further advancement of these efforts.
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